Darwin Gosal·2d agoWho Reads the Genome?Singapore is preparing to read the genomes of nearly half a million people,but who gets to decide what those revelations mean for our…
Mark Perloe·Nov 3The Missing Discipline in Prostate Cancer Care: Precision MedicineWhy AI-enabled integration of multidisciplinary expertise may be the key to optimal survivorship for men with advanced prostate cancer.A response icon1A response icon1
Fernan D. Cardona·Oct 29An Introduction to Evidence-Based Medicine: Internist Doctor Carlos Rivas, Integrative Practice.An alternative to mainstream, outdated medicine and pharma-driven frameworks.
Fernan D. Cardona·Oct 27Dr. Rivas is the official Health Provider for the Tapering and Healing Temple — Partnership…Why this matters for the iatrogenically injured community, and how precision diagnosis and treatment can break through the therapeutic…
Mark Perloe·Oct 18Beyond the Press Release: Navigating the 17-Year Gap in the Prostate Cancer EcosystemWhy Millions of Men Face Fragmented Care: Closing the Gap with Precision Diagnostics and AIA response icon1A response icon1
Seababyyy·Sep 27☔🌲 BIOMEDICAL SCIENCE AND BIOMEDICAL ENGINEERING: KNOWLEDGE AND TECHNOLOGY FOR LIFE 🍒🌿 🍨☃️…🤎 Today, amid unprecedented scientific progress, two fields — Biomedical Science and Biomedical Engineering — have emerged as the most…
OncoFrontier·Sep 24A Startup Is Building a Simulated Tumour to Test Drug Combinations Before a Patient Ever Gets OneBig Picture Bio raised 2.55 million euros for a generative “world model” that simulates how tumours, immune cells, and tissue interact…
Nairnanditha·Sep 19The Future of Healthcare Is Predictive, Preventive, and Personalized- But Prediction Isn’t…Healthcare is getting remarkably good at detecting risk. The harder question is whether we know what to do with it.
Andrea Catalano·Sep 15My Next Pick: Not a Drug. The Infrastructure Behind Every Drug.There’s a version of this story where the problem is just that cancer drug development costs too much. That’s true, but it’s not the real…
Sampath Koppole·Sep 5A Molecule Is Not a Medicine: Rethinking AI Drug Discovery Beyond Binding ScoresA molecule can bind beautifully, score well in QSAR models, show a reassuring early toxicity profile and even produce encouraging Phase II…
